Compare TLS & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLS | SMTI |
|---|---|---|
| Founded | 1969 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.0M | 313.5M |
| IPO Year | 2020 | 2008 |
| Metric | TLS | SMTI |
|---|---|---|
| Price | $4.23 | $34.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | $6.33 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 621.2K | 181.9K |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.51 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $164,805,000.00 | $15,586,976.00 |
| Revenue This Year | $16.14 | $13.07 |
| Revenue Next Year | $0.26 | $14.23 |
| P/E Ratio | $135.67 | ★ N/A |
| Revenue Growth | ★ 52.21 | 32.47 |
| 52 Week Low | $3.79 | $16.05 |
| 52 Week High | $8.36 | $35.34 |
| Indicator | TLS | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 64.96 |
| Support Level | $4.07 | $33.99 |
| Resistance Level | $4.68 | $35.34 |
| Average True Range (ATR) | 0.14 | 0.20 |
| MACD | 0.00 | -0.16 |
| Stochastic Oscillator | 57.65 | 50.79 |
Telos Corp offers technology solutions and services that empower and protect the world's security-conscious organizations. The company delivers efficient, adaptable, and secure solutions that protect people, organizations, and information across government and industry. The company conducts its business through two reportable and operating segments: Security Solutions and Secure Networks. The Security Solutions segment is focused on cybersecurity, cloud, and identity solutions, and secure messaging through Xacta, Telos AMHS, and Telos ID offerings. The Secure Networks segment provides secure networking architectures and solutions to customers through secure mobility solutions, network management, and defense services. The majority of revenue is from Secure Networks.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.